Zobrazeno 1 - 10
of 161
pro vyhledávání: '"Luigi Pirtoli"'
Autor:
Tomer Meirson, Valerio Nardone, Francesca Pentimalli, Gal Markel, David Bomze, Maria D’Apolito, Pierpaolo Correale, Antonio Giordano, Luigi Pirtoli, Camillo Porta, Steven G Gray, Luciano Mutti
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract In this commentary, using existing clinical trial data and FDA approvals we propose that there is currently a critical need for an appropriate balancing between the financial impact of new cancer drugs and their actual benefit for patients.
Externí odkaz:
https://doaj.org/article/31b55a1ccc204e26bbba66e8945e4d5e
Autor:
Antonella Fameli, Valerio Nardone, Mojtaba Shekarkar Azgomi, Giovanna Bianco, Claudia Gandolfo, Bianca Maria Oliva, Marika Monoriti, Rita Emilena Saladino, Antonella Falzea, Caterina Romeo, Natale Daniele Calandruccio, Domenico Azzarello, Rocco Giannicola, Luigi Pirtoli, Antonio Giordano, Pierfrancesco Tassone, Pierosandro Tagliaferri, Maria Grazia Cusi, Luciano Mutti, Cirino Botta, Pierpaolo Correale
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Peripheral immune-checkpoint blockade with mAbs to programmed cell death receptor-1 (PD-1) (either nivolumab or pembrolizumab) or PD-Ligand-1 (PD-L1) (atezolizumab, durvalumab, or avelumab) alone or in combination with doublet chemotherapy represents
Externí odkaz:
https://doaj.org/article/7c83e17e42a94c91add14fbda6384ccb
Autor:
Valerio Nardone, Rocco Giannicola, Giovanna Bianco, Diana Giannarelli, Paolo Tini, Pierpaolo Pastina, Antonia Consuelo Falzea, Sebastiano Macheda, Michele Caraglia, Amalia Luce, Silvia Zappavigna, Luciano Mutti, Luigi Pirtoli, Antonio Giordano, Pierpaolo Correale
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Peripheral-immune-checkpoint blockade (P-ICB) with mAbs to PD-1 (nivolumab and pembrolizumab) or PD-L1 (atezolizumab, durvalumab, avelumab) alone or combination with chemotherapy represents a novel active treatment for mNSCLC patients. However, this
Externí odkaz:
https://doaj.org/article/44c6f43b72ed4333ad3dfa420b56c3ce
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 12, p 6831 (2022)
MicroRNAs (miRNAs) are a class of small non-coding RNAs around 22 nucleotides long that regulate gene expression by binding specific sequences within target messenger RNA (mRNA) [...]
Externí odkaz:
https://doaj.org/article/16c62931fc81489bb0d8787ccb8c80a8
Autor:
Michele Caraglia, Pierpaolo Correale, Rocco Giannicola, Nicoletta Staropoli, Cirino Botta, Pierpaolo Pastina, Antonello Nesci, Nadia Caporlingua, Edoardo Francini, Laura Ridolfi, Enrico Mini, Giandomenico Roviello, Domenico Ciliberto, Rita Maria Agostino, Alessandra Strangio, Domenico Azzarello, Valerio Nardone, Antonella Falzea, Salvatore Cappabianca, Marco Bocchetti, Graziella D'Arrigo, Giovanni Tripepi, Pierfrancesco Tassone, Raffaele Addeo, Antonio Giordano, Luigi Pirtoli, Guido Francini, Pierosandro Tagliaferri
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: GOLFIG is a chemo-immunotherapy regimen established in preclinical models that combines gemcitabine + FOLFOX (fluoropyrimidine backbone coupled to oxaliplatin) poly-chemotherapy with low-dose s. c. recombinant interleukin-2 (rIL-2) and gr
Externí odkaz:
https://doaj.org/article/7170bd6fde8f4eec8eb14aa1cf9dfeb1
Autor:
Valerio Nardone, Rocco Giannicola, Diana Giannarelli, Rita Emilena Saladino, Domenico Azzarello, Caterina Romeo, Giovanna Bianco, Maria Rosaria Rizzo, Irene Di Meo, Antonio Nesci, Pierpaolo Pastina, Antonia Consuelo Falzea, Daniele Caracciolo, Alfonso Reginelli, Michele Caraglia, Amalia Luce, Luciano Mutti, Antonio Giordano, Salvatore Cappabianca, Luigi Pirtoli, Vito Barbieri, Pierfrancesco Tassone, Pierosandro Tagliaferri, Pierpaolo Correale
Publikováno v:
Life, Vol 11, Iss 11, p 1235 (2021)
An immune checkpoint blockade with mAbs to PD-1 and PD-L1 is an expanding therapeutic option for mNSCLC patients. This treatment strategy is based on the use of mAbs able to restore the anti-tumor activity of intratumoral T cells inhibited by PD-1 bi
Externí odkaz:
https://doaj.org/article/62314baa55cc425bb501c2b7b1efcaef
Autor:
Valerio Nardone, Marcella Barbarino, Antonio Angrisani, Pierpaolo Correale, Pierpaolo Pastina, Salvatore Cappabianca, Alfonso Reginelli, Luciano Mutti, Clelia Miracco, Rocco Giannicola, Antonio Giordano, Luigi Pirtoli
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 16, p 8391 (2021)
The expanding clinical application of CDK4- and CDK6-inhibiting drugs in the managements of breast cancer has raised a great interest in testing these drugs in other neoplasms. The potential of combining these drugs with other therapeutic approaches
Externí odkaz:
https://doaj.org/article/243d17d65b1c4011b4886e1439439fa1
Autor:
Valerio Nardone, Alfonso Reginelli, Fernando Scala, Salvatore Francesco Carbone, Maria Antonietta Mazzei, Lucio Sebaste, Tommaso Carfagno, Giuseppe Battaglia, Pierpaolo Pastina, Pierpaolo Correale, Paolo Tini, Gianluca Pellino, Salvatore Cappabianca, Luigi Pirtoli
Publikováno v:
Gastroenterology Research and Practice, Vol 2019 (2019)
Background. We hypothesized that texture analysis (TA) from the preoperative MRI can predict early disease progression (ePD), defined as the percentage of patients who relapsed or showed distant metastasis within three months from the radical surgery
Externí odkaz:
https://doaj.org/article/c2eddc4e5fb04b6db213d92c54ed92c6
Autor:
Valerio Nardone, Pierpaolo Pastina, Rocco Giannicola, Rita Agostino, Stefania Croci, Paolo Tini, Luigi Pirtoli, Antonio Giordano, Pierosandro Tagliaferri, Pierpaolo Correale
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Externí odkaz:
https://doaj.org/article/543c0c2eca674be697007e77d6ae499c
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 16, p 5625 (2020)
Aromatase inhibitors (AIs) have radically changed the prognosis of hormone receptor positive breast cancer (BC) in post-menopausal women, and are a mainstay of the adjuvant therapy for BC after surgery in place of, or following, Tamoxifen. However, A
Externí odkaz:
https://doaj.org/article/41e46d23ef354696b804736bc23e2467